High Mean Corpuscular Volume Predicts Poor Outcome for Patients With Gastroesophageal Adenocarcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-4681
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
High Mean Corpuscular Volume Predicts Poor Outcome for Patients With Gastroesophageal Adenocarcinoma ; volume:26 ; number:4 ; day:31 ; month:1 ; year:2019 ; pages:976-985 ; date:4.2019
Annals of surgical oncology ; 26, Heft 4 (31.1.2019), 976-985, 4.2019
- Creator
-
Jomrich, Gerd
Hollenstein, Marlene
John, Max
Ristl, Robin
Paireder, Matthias
Kristo, Ivan
Asari, Reza
Schoppmann, Sebastian Friedrich
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1245/s10434-019-07186-1
- URN
-
urn:nbn:de:101:1-2019033004191461986211
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jomrich, Gerd
- Hollenstein, Marlene
- John, Max
- Ristl, Robin
- Paireder, Matthias
- Kristo, Ivan
- Asari, Reza
- Schoppmann, Sebastian Friedrich
- SpringerLink (Online service)
Other Objects (12)
Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma
High expression of DEK predicts poor prognosis of gastric adenocarcinoma
CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma
Decreased mean platelet volume predicts poor prognosis in patients with pancreatic cancer
Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma
Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma
Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma
Overexpression of CDCA8 predicts poor prognosis and drug insensitivity in lung adenocarcinoma
CASTOR1 phosphorylation predicts poor survival in male patients with KRAS-mutated lung adenocarcinoma
High PKD2 predicts poor prognosis in lung adenocarcinoma via promoting Epithelial–mesenchymal Transition
Long-Term Survival in Gastroesophageal Junction Adenocarcinoma: Ramucirumab
Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma
High expression of DEK predicts poor prognosis of gastric adenocarcinoma
CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma
Decreased mean platelet volume predicts poor prognosis in patients with pancreatic cancer
Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma
Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma
Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma
Overexpression of CDCA8 predicts poor prognosis and drug insensitivity in lung adenocarcinoma
CASTOR1 phosphorylation predicts poor survival in male patients with KRAS-mutated lung adenocarcinoma
High PKD2 predicts poor prognosis in lung adenocarcinoma via promoting Epithelial–mesenchymal Transition
Long-Term Survival in Gastroesophageal Junction Adenocarcinoma: Ramucirumab
Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma
High expression of DEK predicts poor prognosis of gastric adenocarcinoma
CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma
Decreased mean platelet volume predicts poor prognosis in patients with pancreatic cancer
Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma
Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma
Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma
Overexpression of CDCA8 predicts poor prognosis and drug insensitivity in lung adenocarcinoma
CASTOR1 phosphorylation predicts poor survival in male patients with KRAS-mutated lung adenocarcinoma
High PKD2 predicts poor prognosis in lung adenocarcinoma via promoting Epithelial–mesenchymal Transition